# Towards the development of human immune-system-on-a-chip platforms

Article · Alessandro Polini, Loretta L. del Mercato, Adriano Barra, Yu Shrike Zhang, Franco Calabi, Giuseppe Gigli

- Archive id: arxiv:2102.13174
- Published: 2021-02-25
- Venue: Drug Discovery Today, 2019
- DOI: https://doi.org/10.1016/j.drudis.2018.10.003
- arXiv: https://arxiv.org/abs/2102.13174
- Citations: 99
- Source URL: https://arxiv.org/abs/2102.13174
- PDF: https://arxiv.org/pdf/2102.13174
- Provenance: arxiv

## Abstract

Organ-on-a-chip (OoCs) platforms could revolutionize drug discovery and might ultimately become essential tools for precision therapy. Although many single-organ and interconnected systems have been described, the immune system has been comparatively neglected, despite its pervasive role in the body and the trend towards newer therapeutic products (i.e., complex biologics, nanoparticles, immune checkpoint inhibitors, and engineered T cells) that often cause, or are based on, immune reactions. In this review, we recapitulate some distinctive features of the immune system before reviewing microfluidic devices that mimic lymphoid organs or other organs and/or tissues with an integrated immune system component.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

Topics: [Cancer Immunotherapy](https://space-kitty.com/topics/cancer-immunotherapy)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.